BackProvectus Biopharmaceuticals Overview

Provectus Biopharmaceuticals Total Revenue

Revenue analysis for PVCT.

Quarterly Revenue

N/A

As of Mar 2026

Annual Revenue (TTM)

$57480.00
↓ 78.66% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin